These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 20621909)

  • 1. Menopausal hormone therapy and risk for cardiovascular disease in the WHI trial.
    Harman SM; Brinton EA; Naftolin F; Merriam GR; Cedars MI; Freeman RG; Santoro N
    Ann Intern Med; 2010 Jul; 153(1):60-1; author reply 61-2. PubMed ID: 20621909
    [No Abstract]   [Full Text] [Related]  

  • 2. Menopausal hormone therapy and risk for cardiovascular disease in the WHI trial.
    Pines A; Sturdee D
    Ann Intern Med; 2010 Jul; 153(1):61; author reply 61-2. PubMed ID: 20621912
    [No Abstract]   [Full Text] [Related]  

  • 3. Menopausal hormone therapy and risk for cardiovascular disease in the WHI trial.
    Sullivan JL
    Ann Intern Med; 2010 Jul; 153(1):61; author reply 61-2. PubMed ID: 20621911
    [No Abstract]   [Full Text] [Related]  

  • 4. Women's health. The vanishing promises of hormone replacement.
    Enserink M
    Science; 2002 Jul; 297(5580):325-6. PubMed ID: 12130763
    [No Abstract]   [Full Text] [Related]  

  • 5. Lung cancer and hormone replacement therapy.
    Canonico M; Plu-Bureau G; Scarabin PY
    Lancet; 2010 Jan; 375(9709):117; author reply 118-9. PubMed ID: 20109882
    [No Abstract]   [Full Text] [Related]  

  • 6. Re: Estrogen plus progestin therapy and breast cancer in recently postmenopausal women.
    Langer RD
    Am J Epidemiol; 2009 Mar; 169(6):784-5; author reply 785-6. PubMed ID: 19208722
    [No Abstract]   [Full Text] [Related]  

  • 7. Summaries for patients: The effect of estrogen plus progestin on coronary heart disease.
    Ann Intern Med; 2010 Feb; 152(4):I-40. PubMed ID: 20157120
    [No Abstract]   [Full Text] [Related]  

  • 8. A clinician's review of the WHI-related literature.
    Speroff L
    Int J Fertil Womens Med; 2004; 49(6):252-67. PubMed ID: 15751264
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Postmenopausal hormone therapy after WHI and HERS].
    Birkhäuser M; de Geyter C; Keller PJ; Luzuy F
    Gynakol Geburtshilfliche Rundsch; 2004 Oct; 44(4):244-8. PubMed ID: 15459524
    [No Abstract]   [Full Text] [Related]  

  • 10. [Health symptom-free women do not need preventive hormone replacement therapy. The risks outweigh the benefits; a large trial prematurely interrupted in the USA].
    von Schoultz B
    Lakartidningen; 2002 Aug; 99(34):3276-8. PubMed ID: 12362844
    [No Abstract]   [Full Text] [Related]  

  • 11. The effect of medroxyprogesterone acetate on estrogen-dependent risks and benefits--an attempt to interpret the Women's Health Initiative results.
    Kuhl H; Stevenson J
    Gynecol Endocrinol; 2006 Jun; 22(6):303-17. PubMed ID: 16785155
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The WHI ten year's later: an epidemiologist's view.
    Lacey JV
    J Steroid Biochem Mol Biol; 2014 Jul; 142():12-5. PubMed ID: 24029430
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Postmenopausal hormone replacement therapy and cardiovascular risk: role of conjugated equine estrogens and medroxyprogesterone acetate].
    Ortmann J; Traupe T; Vetter W; Barton M
    Praxis (Bern 1994); 2004 May; 93(21):904-14. PubMed ID: 15216975
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New information about hormone therapy and cardiovascular disease prevention in women.
    Goldie MP
    Int J Dent Hyg; 2007 Aug; 5(3):190-3. PubMed ID: 17615030
    [No Abstract]   [Full Text] [Related]  

  • 15. Post-menopausal hormone replacement therapy (cont'd): risk-benefit balance in the hot seat.
    Prescrire Int; 2004 Jun; 13(71):106-9. PubMed ID: 15233153
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ACOG Committee Opinion No. 420, November 2008: hormone therapy and heart disease.
    American College of Obstetricians and Gynecologists Committee on Gynecologic Practice
    Obstet Gynecol; 2008 Nov; 112(5):1189-92. PubMed ID: 18978127
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New evidence regarding hormone replacement therapies is urgently required transdermal postmenopausal hormone therapy differs from oral hormone therapy in risks and benefits.
    Modena MG; Sismondi P; Mueck AO; Kuttenn F; Lignières Bd; Verhaeghe J; Foidart JM; Caufriez A; Genazzani AR;
    Maturitas; 2005 Sep; 52(1):1-10. PubMed ID: 15963666
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiovascular and metabolic effects of medroxyprogesterone acetate versus conjugated equine estrogen after premenopausal hysterectomy with bilateral ovariectomy.
    Kalyan S; Hitchcock CL; Sirrs S; Pudek M; Prior JC
    Pharmacotherapy; 2010 May; 30(5):442-52. PubMed ID: 20411996
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Abbreviated hormone replacement therapy trial answers some questions, raises new ones. The Women's Health Initiative is no longer testing the most widely prescribed estrogen and progestin combination--but the study's job is far from over.
    Harv Womens Health Watch; 2002 Oct; 10(2):2-4. PubMed ID: 12393317
    [No Abstract]   [Full Text] [Related]  

  • 20. Estrogen research. Brain researchers try to salvage estrogen treatments.
    Wickelgren I
    Science; 2003 Nov; 302(5648):1138-9. PubMed ID: 14615509
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.